| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Depreciation | 133,095 | 88,760 |
| Change in straight-line rent receivable | -45,965 | -58,586 |
| Amortization of operating lease right-of-use asset | 48,755 | 33,628 |
| Stock-based compensation and service expense | 1,422,978 | 761,698 |
| Amortization of debt issuance costs and debt discount | 1,155,310 | 1,123,971 |
| Loss on extinguishment of debt | 9,076,587 | 9,076,587 |
| Rent receivable | 4,634 | 6,381 |
| Security deposit | 17,412 | 17,332 |
| Deferred leasing costs | 23,732 | - |
| Prepaid expense and other assets | 184,630 | 254,918 |
| Accrued liabilities and other payables | 985,228 | 1,220,868 |
| Operating lease obligation | -48,755 | -33,628 |
| Change in fair market value of derivative liability | -471,946 | -446,816 |
| Credit loss provision | - | 1,650,000 |
| (income) loss from equity method investment | 392,677 | 392,677 |
| Deferred leasing costs | - | 15,877 |
| Net loss | -16,194,977 | -15,940,709 |
| Distribution of earnings from equity method investment | 0 | - |
| Accrued liabilities and other payables - related parties | 0 | - |
| Net cash used in operating activities | -4,388,557 | -3,027,822 |
| Improvement of commercial real estate | 35,865 | - |
| Proceeds from sale of equity method investment | 788,500 | 95,000 |
| Payment for equity interest purchase | 0 | 0 |
| Net cash provided by (used in) investing activities | 752,635 | 95,000 |
| Proceeds from issuance of convertible debt | 200,000 | - |
| Advance from pending sale of noncontrolling interest in subsidiary | 49,972 | 149,972 |
| Proceeds from issuance of convertible preferred stock | 300,000 | 0 |
| Payments of convertible preferred stock issuance costs | 10,000 | - |
| Proceeds from issuance of common stock and warrants | 475,500 | - |
| Payments of offering costs | 52,601 | 22,336 |
| Proceeds from stock subscription liability | 150,000 | - |
| Proceeds from issuance of convertible debt and warrants | 0 | - |
| Payments of convertible debt issuance costs | 0 | 0 |
| Repayments of convertible debt | 0 | 0 |
| Proceeds from equity offering | 0 | - |
| Proceeds from stock subscription liability | - | 150,000 |
| Disbursements for equity offering costs | 0 | - |
| Net cash provided by financing activities | 1,112,871 | 277,636 |
| Effect of exchange rate on cash | 673 | 409 |
| Net (decrease) increase in cash | -2,522,378 | -2,654,777 |
| Cash and cash equivalents at beginning of period | 2,856,309 | - |
| Cash and cash equivalents at end of period | 333,931 | - |
Avalon GloboCare Corp. (ALBT)
Avalon GloboCare Corp. (ALBT)